Oxytocin’s social and stress-regulatory effects in children with autism and intellectual disability: a protocol for a randomized placebo-controlled trial

Abstract Background Oxytocin is increasingly considered as a new pharmacological option for mitigating social difficulties and regulating stress in autism spectrum disorder. However, in prior trials, autistic individuals with co-occurring intellectual disability (ID) have largely been overlooked, de...

Descrizione completa

Dettagli Bibliografici

Autori principali:	G. Ricchiuti, A. Taillieu, E. Tuerlinckx, J. Prinsen, E. Debbaut, J. Steyaert, B. Boets, Kaat Alaerts
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2025-03-01
Serie:	BMC Psychiatry
Soggetti:	Oxytocin Children Autism Intellectual disability Clinical trial
Accesso online:	https://doi.org/10.1186/s12888-025-06617-6
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!